Company intelligence / Profile preview

Wakunaga Pharmaceutical Company

Ownership
Private
Development stage
Phase 1
01

Overview

Wakunaga’s flagship product, Kyolic Aged Garlic Extract™, has been the subject of over 900 published scientific papers, including many double-blind, randomized controlled trials. These studies have demonstrated benefits such as lowering blood pressure and cholesterol, slowing progression of atherosclerosis by reducing plaque buildup and calcium deposits in arteries, enhancing circulation, supporting immune function, aiding blood sugar control and liver health. Their probiotic line (“Kyo-Dophilus”) uses proprietary strains shown to improve gut microbiota balance and digestive/immune health. Plant sterol products have also been clinically shown to lower cholesterol and modulate immune response.

Therapeutic areas
GastroenterologyCardiovascularImmunologyEndocrinologyOther
Modalities
Natural products (Aged Garlic Extract, probiotics, plant sterols)Dietary supplements
Industry
Food & Nutrition
02

Drug pipeline

3 assets

WN-1316

Phase 1
Indications
Amyotrophic Lateral Sclerosis

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Wakunaga Pharmaceutical Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wakunaga Pharmaceutical Company.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call